Showing results (1-10 of 24) with videos related to
Sort By:
Pageof 3
Journal of Medical Virology|October 12, 2013
Residual viremia in patients on antiretroviral therapy incorporating nevirapine is not associated with the gag-specific cellular immune responseDorian McIlroy, Clotilde Allavena, Audrey Rodallec, et al.Research in Microbiology|February 5, 2004
Quantification of human astroviruses in sewage using real-time RT-PCRPierre Le Cann, Sandrine Ranarijaona, Serge Monpoeho, et al.Journal of Medical Virology|September 5, 2002
Prolonged hepatitis A infection in an HIV-1 seropositive patientMauro Costa-Mattioli, Clotilde Allavena, Anne-Sophie Poirier, et al.HIV Clinical Trials|June 29, 2005
Salvage therapy with ritonavir-boosted amprenavir/fosamprenavir: virological and immunological response in two years follow-upRomina Quercia, Elisabeth Garnier, Virginie Ferré, et al.The Journal of General Virology|December 3, 2003
Genetic variability of hepatitis A virusMauro Costa-Mattioli, Anna Di Napoli, Virginie Ferré, et al.International Journal of Food Microbiology|May 11, 2007
Detection and quantification by real-time RT-PCR of hepatitis A virus from inoculated tap waters, salad vegetables, and soft fruits: characterization of the method performancesEric Dubois, Catherine Hennechart, Ghislaine Merle, et al.Journal of Medical Virology|July 18, 2013
Evaluation of residual viremia and quantitation of soluble CD14 in a large cohort of HIV-infected adults on a long-term non-nucleoside reverse transcriptase inhibitor-based regimenClotilde Allavena, Audrey Rodallec, Solène Sécher, et al.International Journal of Food Microbiology|January 3, 2006
Intra-laboratory validation of a concentration method adapted for the enumeration of infectious F-specific RNA coliphage, enterovirus, and hepatitis A virus from inoculated leaves of salad vegetablesEric Dubois, Catherine Hennechart, Nathalie Deboosère, et al.Antiviral Therapy|October 23, 2013
Nevirapine-raltegravir combination, an NRTI and PI/r sparing regimen, as maintenance antiretroviral therapy in virologically suppressed HIV-1-infected patientsVéronique Reliquet, Catherine Chirouze, Clotilde Allavena, et al.Antimicrobial Agents and Chemotherapy|October 25, 2003
R57K polymorphism in the human immunodeficiency virus type 1 protease as predictor of early virological failure in a cohort of antiretroviral-naive patients treated mostly with a nelfinavir-containing regimenBernard Masquelier, Cecile Droz, Martin Dary, et al.Pageof 3